A Potential Chinese Medicine Granule Suppressing ARDS of COVID-19:Keguan-1

• 作 者: ZHONG Nan-shan YANG Zi-feng JIANG Mei LIANG Jing-yi
• 机 构: State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Diseas
• 出 处: 中国结合医学杂志（英文版）
• 发表日期: 2020年11期

Recently,a well-designed,exploratory clinical trial on the management of patients with coronavirus disease 2019 (COVID-19) by a Chinese medicine(CM) Keguan-1 has been conducted by Dr.XIAO Xiao-he and his colleagues.(1) For the emergency of COVID-19 treatment,conventional new vaccine and new drug development is a money consuming and time demanding process.Consequently,it is a realistic choice to explore potential therapeutic drugs among repurposing drugs such as hydroxychloroquine and remdesivir.